表紙
市場調查報告書
商品編碼
1027687

全球治療用肉毒桿菌市場

Therapeutic Botulinum Toxin | Medtech 360 | Market Insights | Global

出版日期: | 出版商: DRG Medtech - Part of Clarivate | 英文 | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

COVID-19大流行,短期性給予全球治療用肉毒桿菌市場負面影響。全球的經濟不安,沒有緊急性的治療延期導致治療數量的減少,阻礙市場成長。可是,COVID-19大流行以後,重新已批准適應,由於肉毒桿菌治療的反復的必要性,良好的償付環境等,到2029年全球治療用BTX市場預計大幅成長。

本報告提供全球治療用肉毒桿菌市場相關調查,市場概要,以及市場預測資料,市場佔有率,競爭情形,各地區的趨勢等資訊。

目錄

全球

概要

摘要整理

  • COVID-19更新
  • 市場概況
  • 競爭力亮點
  • 市場趨勢
  • 對象地區
  • 對象手術
  • 目標產品

報告主要的更新內容

COVID-19分析

  • 對市場的影響
  • 主要的市場預測的變化與假設
  • 競爭的影響

全球治療用肉毒桿菌市場

  • 市場概況
  • 市場定義
  • 市場預測資料
  • 競爭力亮點
  • 市場佔有率
  • 競爭要素與策略
    • 首發者的分數領先
    • 產品投資組合管理
    • 產品的改善與創新
    • 法規環境
    • 合併,收購,及夥伴關係
    • 替代方案的競爭
    • 價格策略和購買選擇
  • 市場趨勢

美國的治療用肉毒桿菌市場

  • 市場概況
  • 市場定義
  • 市場預測資料
  • 競爭力亮點
  • 市場佔有率
  • 競爭要素與策略

歐洲的治療用肉毒桿菌市場

  • 市場概況
  • 市場定義
  • 市場預測資料
  • 競爭力亮點
  • 市場佔有率
  • 競爭要素與策略

亞太地區的治療用肉毒桿菌市場

  • 市場概況
  • 市場定義
  • 市場預測資料
  • 競爭力亮點
  • 市場佔有率
  • 競爭要素與策略
    • 價格策略和購買選擇

附錄

  • 簡稱
  • 參考文件

調查手法

目錄

The COVID-19 pandemic will have a negative short-term effect on the global therapeutic BTX market. The deferral of nonurgent procedures, compounded with economic uncertainty across the globe will hinder procedure volumes and therefore impede market growth. Beyond the COVID-19 pandemic, the global therapeutic BTX market will grow strongly through 2029, with newly approved indications, the need for repeat BTX treatments, and a largely favorable reimbursement environment driving significant procedure volume and unit sales expansion.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for therapeutic BTX in the US, France, Germany, Italy, Spain, the UK, Japan and Australia across a 10-year period.

The COVID-19 pandemic will hinder growth of the global therapeutic BTX market in the near-term.

  • To what extent will COVID-19 impact the therapeutic BTX market globally?
  • Which geographies have experienced the largest impact, and how quickly are procedure volumes expected to recover?
  • How are manufacturers preparing for the postpandemic environment?

New indication approvals and existing indication expansions will be significant drivers in the therapeutic BTX market.

  • Which indications contribute the most to growth?
  • What regional differences exist regarding indication approvals?
  • What new indications have the largest market potential?

The global therapeutic markets are becoming more and more consolidated.

  • What are some key competitive strategies being employed to succeed in the market?
  • How do the competitive landscapes differ by region, and what considerations must companies make in particular markets?

Markets vary greatly by region in terms of size and growth, with the US market experiencing the fastest growth globally.

  • What key drivers contribute to a market's relative size and growth?
  • What factors most significantly affect pricing within markets?

Ongoing clinical trials and emerging products could have a significant impact on the BTX market in the future.

  • Which clinical trials have been successful and will have significant impact on the market?
  • Will emerging products expand on or compete against the existing BTX market?
  • What are some potential competitive advantages emerging products might have?
  • How will alternative treatments impact the BTX market?

Table of Contents

Global

Abstract

Executive Summary

  • COVID-19 Updates
  • Market Highlights
  • Competitive Highlights
  • Market Developments
  • Geographies Covered
  • Procedures Covered
  • Products Covered

Key Report Updates

COVID-19 Analysis

  • Market Impact
  • Major Market Forecast Changes and Assumptions
  • Competitive Impact

Global Therapeutic Botulinum Toxin Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies
    • First-Mover Advantage
    • Product Portfolio Management
    • Product Improvements and Innovations
    • Regulatory Environment
    • Mergers, Acquisitions, and Partnerships
    • Competition From Alternatives
    • Pricing Strategies and Purchasing Options
  • Market Developments

US Therapeutic Botulinum Toxin Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies

European Therapeutic Botulinum Toxin Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies

Asia Pacific Therapeutic Botulinum Toxin Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies
    • Pricing Strategies and Purchasing Options

Appendix

  • Abbreviations
  • Bibliography

Methodology

  • Core Country Coverage Methodology
  • Research Methodology
  • Marketrack Methodology
  • PriceTrack Methodology
  • Forecast Methodology
  • Supplemental Country Coverage Methodology
  • Base-Year Ratio Analysis
  • Market Forecasting

Tables and Figures

  • Factors Impacting the Therapeutic BTX Market, Global
  • Therapeutic BTX Market, by Region, Global (USD), 2019-2030
  • Therapeutic BTX Market Landscape, Global (USD), 2020 and 2030
  • Competitive Factors and Strategies, by Region
  • Therapeutic BTX Revenue Market Share Rankings, by Region, Global, 2020
  • Companies Mentioned
  • Recent Events in the Therapeutic BTX Market, Global
  • Key Clinical Trials in the Therapeutic BTX Market, Global
  • Emerging Products for the Therapeutic BTX Market, Global
  • Geographies Covered, Global
  • Average Currency Exchange Rates
  • Therapeutic BTX Procedures Covered, US
  • Approved Indications, by Brand, US, 2020/2021
  • Therapeutic BTX Procedures Covered, Europe
  • Approved Indications, by Brand, Europe, 2020/2021
  • Therapeutic BTX Procedures Covered, Asia Pacific
  • Approved Indications, by Brand, Asia Pacific, 2020/2021
  • Therapeutic BTX Product Overview, Global, 2020/2021
  • COVID-19 Impact Assessment Summary, Therapeutic BTX Market, Global
  • Therapeutic BTX Market, by Region, Global (USD), 2019-2030 (Excluding COVID-19 Impact)
  • Therapeutic BTX Market, by Region, Global (USD), 2019-2030 (Including COVID-19 Impact)
  • COVID-19 Competitive Factors and Strategies, Therapeutic BTX Market, Global
  • COVID-19 Financial Impact and Competitor Insights
  • Factors Impacting the Therapeutic BTX Market, Global
  • Therapeutic BTX Market, by Region, Global (USD), 2019-2030
  • Therapeutic BTX Product Overview, Global, 2020/2021
  • Mean Dosages, by Indication and Brand, Global
  • BTX Units Used per Procedure, by Indication, Global
  • BTX Product Equivalencies, by Brand
  • Approved Indications, by Brand, US, 2020/2021
  • Approved Indications, by Brand, Europe, 2020/2021
  • Approved Indications, by Brand, Asia Pacific, 2020/2021
  • Therapeutic BTX Procedures, by Indication, Global, 2019-2030
  • Therapeutic BTX Procedures, by Region, Global, 2019-2030
  • Therapeutic BTX Market, by Indication, Global (USD), 2019-2030
  • Therapeutic BTX Market, by Region, Global (USD), 2019-2030
  • Therapeutic BTX Market Growth, by Region, Global, 2020-2030
  • Therapeutic BTX Revenue Market Shares, Global, 2020
  • Therapeutic BTX Revenue Market Shares, by Region, Global, 2020
  • Competitive Factors and Strategies, by Region
  • Recent Events in the Therapeutic BTX Market, Global
  • Key Clinical Trials in the Therapeutic BTX Market, Global
  • Emerging Products for the Therapeutic BTX Market, Global
  • Therapeutic BTX Market, US (USD), 2019-2030
  • Therapeutic BTX Procedures, by Indication, US, 2019-2030
  • Spasticity Therapeutic BTX Procedures, by Anatomy, US, 2019-2030
  • Spasticity Therapeutic BTX Procedures, by Age Group, US, 2019-2030
  • Overactive Bladder Therapeutic BTX Procedures, by Cause, US, 2019-2030
  • Therapeutic BTX Market, by Indication, US (USD), 2019-2030
  • Therapeutic BTX Market, US (USD), 2019-2030
  • Therapeutic BTX Revenue Market Shares, US 2020
  • Therapeutic BTX Revenue Market Shares, US, 2020
  • Competitive Factors and Strategies, US
  • Therapeutic BTX Market, by Country, Europe (USD), 2019-2030
  • Therapeutic BTX Procedures, by Indication, Europe, 2019-2030
  • Therapeutic BTX Procedures, by Country, Europe, 2019-2030
  • Therapeutic BTX Procedures, by Indication, France, 2019-2030
  • Therapeutic BTX Procedures, by Indication, Germany, 2019-2030
  • Therapeutic BTX Procedures, by Indication, Italy, 2019-2030
  • Therapeutic BTX Procedures, by Indication, Spain, 2019-2030
  • Therapeutic BTX Procedures, by Indication, UK, 2019-2030
  • Therapeutic BTX Market, by Indication, Europe (USD and EUR), 2019-2030
  • Therapeutic BTX Market, by Country, Europe (USD), 2019-2030
  • Therapeutic BTX Market, by Country, Europe (EUR and GBP), 2019-2030
  • Therapeutic BTX Market Growth, by Country, Europe, 2020-2030
  • Therapeutic BTX Market, by Indication, France (USD and EUR), 2019-2030
  • Therapeutic BTX Market, by Indication, Germany (USD and EUR), 2019-2030
  • Therapeutic BTX Market, by Indication, Italy (USD and EUR), 2019-2030
  • Therapeutic BTX Market, by Indication, Spain (USD and EUR), 2019-2030
  • Therapeutic BTX Market, by Indication, UK (USD and EUR), 2019-2030
  • Therapeutic BTX Market, by Indication, UK (GBP), 2019-2030
  • Therapeutic BTX Revenue Market Shares, Europe, 2020
  • Therapeutic BTX Revenue Market Shares, by Country, Europe, 2020
  • Competitive Factors and Strategies, by Country, Europe
  • Therapeutic BTX Market, by Country, Asia Pacific (USD), 2019-2030
  • Therapeutic BTX Procedures, by Indication, Asia Pacific, 2019-2030
  • Therapeutic BTX Procedures, by Country, Asia Pacific, 2019-2030
  • Therapeutic BTX Procedures, by Indication, Australia, 2019-2030
  • Spasticity Therapeutic BTX Procedures, by Anatomy, Australia, 2019-2030
  • Spasticity Therapeutic BTX Procedures, by Age Group, Australia, 2019-2030
  • Overactive Bladder Therapeutic BTX Procedures, by Cause, Australia, 2019-2030
  • Therapeutic BTX Procedures, by Indication, Japan, 2019-2030
  • Therapeutic BTX Market, by Indication, Asia Pacific (USD), 2019-2030
  • Therapeutic BTX Market, by Country, Asia Pacific (USD), 2019-2030
  • Therapeutic BTX Market, by Indication, Australia (USD), 2019-2030
  • Therapeutic BTX Market, Australia (USD), 2019-2030
  • Therapeutic BTX Market, by Indication, Japan (USD), 2019-2030
  • Therapeutic BTX Market, Japan (USD), 2019-2030
  • Therapeutic BTX Revenue Market Shares, Asia Pacific, 2020
  • Therapeutic BTX Revenue Market Shares, by Country, Asia Pacific, 2020
  • Competitive Factors and Strategies, by Country, Asia Pacific
  • Abbreviations